Market Cap 1.16B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 5,990,600
Avg Vol 4,061,914
Day's Range N/A - N/A
Shares Out 303.16M
Stochastic %K 63%
Beta 0.85
Analysts Strong Sell
Price Target $9.50

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
BinaryLogic
BinaryLogic May. 1 at 7:04 AM
$MIST $RCKT $ABCL RANI $OBIO SCNX UNCY COCH JSPR $IMRX Small bio-pharma has been relatively quiet during the current/latest uptrend by comparison placing these (and comparable) stocks at favorable investment levels (IMO). Here is a list of interesting small bio-pharma Companies, each with 25-50% upside from current levels near term and multiplier upside intermediate/long term with meaningful progress on lead drug/treatment candidates.
0 · Reply
History101
History101 May. 1 at 4:38 AM
$ABCL 8,296 watching 4/30/2026
0 · Reply
Themk
Themk May. 1 at 12:57 AM
$ABCL hope this dose not move much waiting on a deal to close I would like to double my position.
1 · Reply
NJgolfer
NJgolfer Apr. 30 at 10:00 PM
$ABCL with a huge volume week and it is only so far with 4 days of trading! Already with 42.88MM shares traded vs avg of 19.74MM. This is the second highest volume up week since the last major move back in first week of June 2025. Something is brewing... and some big buyers stepped in this week. Weekly Chaikin MF/OBV/AD combo turned positive last week and this tends to be a reliable indicator of upside ahead.
0 · Reply
DeMampCamp
DeMampCamp Apr. 30 at 9:13 PM
$ABCL What an absolute beast of a close today! The sky was falling yesterday and today it's like it never happened! Let's see what tomorrow holds! Time for a drink here soon, cheers!
1 · Reply
UncleTomFlorida
UncleTomFlorida Apr. 30 at 8:14 PM
$IBRX $ABCL The shorties are concentrating today on $IBRX - at least so far. Maybe one or both of my low bids will be accepted before midnight. Every share I buy is a long term hold - 5 to 10 years. Suck it up, Shorties.
0 · Reply
8008track
8008track Apr. 30 at 8:11 PM
$ABCL the last couple of days… I’m holding on regardless of what happens with price action. Curious to see at happens up to and after preclinical and Phase 1 readout!
0 · Reply
DeMampCamp
DeMampCamp Apr. 30 at 4:43 PM
$ABCL How many short timers did we flush out yesterday? Great rebound so far!
1 · Reply
TradeWinner
TradeWinner Apr. 30 at 3:53 PM
$ABCL and back to our regularly scheduled program.
0 · Reply
Rastafari
Rastafari Apr. 30 at 3:33 PM
$ABCL Thank you Carl!
1 · Reply
Latest News on ABCL
AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 2 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 6 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 6 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 8 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 9 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Announces Resignation of Board Member

Feb 23, 2024, 4:30 PM EST - 2 years ago

AbCellera Announces Resignation of Board Member


AbCellera Biologics Earnings Call Transcript: Q4 2023

Feb 20, 2024, 5:00 PM EST - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2023


AbCellera Biologics Earnings Call Transcript: Q3 2023

Nov 2, 2023, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2023


AbCellera Biologics Earnings Call Transcript: Q2 2023

Aug 3, 2023, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2023


AbCellera Biologics Earnings Call Transcript: Q1 2023

May 4, 2023, 5:00 PM EDT - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2023


AbCellera Biologics Earnings Call Transcript: Q4 2022

Feb 21, 2023, 5:00 PM EST - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2022


AbCellera Biologics Transcript: JPMorgan Healthcare Conference

Jan 11, 2023, 5:15 PM EST - 3 years ago

AbCellera Biologics Transcript: JPMorgan Healthcare Conference


AbCellera Biologics Earnings Call Transcript: Q3 2022

Nov 8, 2022, 5:00 PM EST - 3 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2022


AbCellera Biologics Earnings Call Transcript: Q2 2022

Aug 9, 2022, 5:00 PM EDT - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2022


AbCellera Biologics Earnings Call Transcript: Q1 2022

May 10, 2022, 8:52 AM EDT - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2022


AbCellera Biologics Earnings Call Transcript: Q4 2021

Feb 24, 2022, 9:23 AM EST - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2021


AbCellera Biologics Earnings Call Transcript: Q3 2021

Nov 8, 2021, 7:00 PM EST - 4 years ago

AbCellera Biologics Earnings Call Transcript: Q3 2021


AbCellera Biologics Earnings Call Transcript: Q2 2021

Aug 12, 2021, 12:02 PM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q2 2021


AbCellera Biologics Earnings Call Transcript: Q1 2021

May 13, 2021, 9:46 AM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2021


AbCellera Biologics Earnings Call Transcript: Q4 2020

Mar 29, 2021, 9:46 AM EDT - 5 years ago

AbCellera Biologics Earnings Call Transcript: Q4 2020


BinaryLogic
BinaryLogic May. 1 at 7:04 AM
$MIST $RCKT $ABCL RANI $OBIO SCNX UNCY COCH JSPR $IMRX Small bio-pharma has been relatively quiet during the current/latest uptrend by comparison placing these (and comparable) stocks at favorable investment levels (IMO). Here is a list of interesting small bio-pharma Companies, each with 25-50% upside from current levels near term and multiplier upside intermediate/long term with meaningful progress on lead drug/treatment candidates.
0 · Reply
History101
History101 May. 1 at 4:38 AM
$ABCL 8,296 watching 4/30/2026
0 · Reply
Themk
Themk May. 1 at 12:57 AM
$ABCL hope this dose not move much waiting on a deal to close I would like to double my position.
1 · Reply
NJgolfer
NJgolfer Apr. 30 at 10:00 PM
$ABCL with a huge volume week and it is only so far with 4 days of trading! Already with 42.88MM shares traded vs avg of 19.74MM. This is the second highest volume up week since the last major move back in first week of June 2025. Something is brewing... and some big buyers stepped in this week. Weekly Chaikin MF/OBV/AD combo turned positive last week and this tends to be a reliable indicator of upside ahead.
0 · Reply
DeMampCamp
DeMampCamp Apr. 30 at 9:13 PM
$ABCL What an absolute beast of a close today! The sky was falling yesterday and today it's like it never happened! Let's see what tomorrow holds! Time for a drink here soon, cheers!
1 · Reply
UncleTomFlorida
UncleTomFlorida Apr. 30 at 8:14 PM
$IBRX $ABCL The shorties are concentrating today on $IBRX - at least so far. Maybe one or both of my low bids will be accepted before midnight. Every share I buy is a long term hold - 5 to 10 years. Suck it up, Shorties.
0 · Reply
8008track
8008track Apr. 30 at 8:11 PM
$ABCL the last couple of days… I’m holding on regardless of what happens with price action. Curious to see at happens up to and after preclinical and Phase 1 readout!
0 · Reply
DeMampCamp
DeMampCamp Apr. 30 at 4:43 PM
$ABCL How many short timers did we flush out yesterday? Great rebound so far!
1 · Reply
TradeWinner
TradeWinner Apr. 30 at 3:53 PM
$ABCL and back to our regularly scheduled program.
0 · Reply
Rastafari
Rastafari Apr. 30 at 3:33 PM
$ABCL Thank you Carl!
1 · Reply
SuperGreenToday
SuperGreenToday Apr. 30 at 3:15 PM
$ABCL Share Price: $3.94 Contract Selected: Oct 16, 2026 $5 Calls Buy Zone: $0.21 – $0.26 Target Zone: $0.37 – $0.46 Potential Upside: 66% ROI Time to Expiration: 168 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
capitalthinktank
capitalthinktank Apr. 30 at 3:00 PM
$ABCL on the monthly timeframe continues to present a structurally bullish long-term setup. The key macro pivot remains the $4.70 level, which acts as the primary threshold for maintaining the broader bullish structure. Price recently approached this zone but has not yet confirmed a decisive breakout beyond it. Volume activity is beginning to re-accelerate after a period of compression, suggesting renewed participation is entering the name. This type of volume expansion at a major monthly resistance area is often critical for trend continuation or breakout validation. As long as price holds above the broader support structure and continues building acceptance near this zone, the long-term technical picture remains constructive. A sustained move and close above $4.70 would further strengthen the breakout thesis and open the door for continuation of the higher timeframe uptrend. Overall, the monthly structure remains intact with improving participation dynamics and a key level now in focus.
0 · Reply
tradersunion353
tradersunion353 Apr. 30 at 1:56 PM
$ABCL Who are these clowns pumping this POS performance Overhyped and underperforming junk Who cares what science they if they are not benefittong investors.. Most of the folks here just married are married. espiecally that Dem guy
0 · Reply
JennyRowes
JennyRowes Apr. 30 at 12:59 PM
$ABCL shareholder letter totally worth reading https://d18rn0p25nwr6d.cloudfront.net/CIK-0001703057/a3205993-6fb1-4f79-8fcb-7863eccb246f.pdf
1 · Reply
DragonAlgo
DragonAlgo Apr. 30 at 3:52 AM
🐉 $ABCL PUT — DragonAlgo® Signal Contract: ABCL PUT Expiry: 2026-10-16 | Strike: $8.00 | Type: PUT Option Plan (premium): Entry: $4.30 Stop: $3.10 TP1: $5.59 TP2: $7.31 TP3: $10.32 🔗 https://dragonalgo.com
0 · Reply
Arcides
Arcides Apr. 29 at 11:38 PM
$ABCL 5 consecutive days with a lot of volume, this is being dumped again.
2 · Reply
UncleTomFlorida
UncleTomFlorida Apr. 29 at 11:33 PM
$ABCL 1, 5, 10 yr price targets courtesy of Probabli.xyz Free A.I.
0 · Reply
DeMampCamp
DeMampCamp Apr. 29 at 11:07 PM
$ABCL If you haven't had a chance to read the annual shareholder report, take some time to do so! This is the type of transparency and I've been yearning for throughout the years, but better late than never! Nasty day here, but without rain there's no rainbow! Chin up, folks, tomorrow's a new day!
1 · Reply
UncleTomFlorida
UncleTomFlorida Apr. 29 at 11:04 PM
0 · Reply
Rastafari
Rastafari Apr. 29 at 10:40 PM
$ABCL what a letter! Glad I added today!
0 · Reply
8008track
8008track Apr. 29 at 9:43 PM
$ABCL Carl Hansen is a long term thinker. If he gets this right, and he intends to, this will go down as an easy 10x. If they crush it, then I could see this being a 100-200x from here. It won’t happen overnight and will take another 10-20 years but it’s definitely possible. Good luck to all the longs!
2 · Reply
8008track
8008track Apr. 29 at 9:19 PM
$ABCL annual report: https://d18rn0p25nwr6d.cloudfront.net/CIK-0001703057/a3205993-6fb1-4f79-8fcb-7863eccb246f.pdf
0 · Reply